Aimei Health Technology Co., Ltd
NASDAQ:AFJKShell Companies
-$3.66 today
- Market cap
- $73.22M
- Beta
- 0.23
- P/E (TTM)
- 34.3
- EPS (TTM)
- $0.88
Volume 0.13M
Average 0.02M
AFJK Total Assets
Everything the company owns or controls; equal to total liabilities plus equity.
Aimei Health Technology Co., LtdNASDAQ: AFJK
Total Assets · Q1 FY2026 · quarter ended Mar 2026
Total assets falls 71.8% from a year ago
Total assets stood at $12.29M at the end of Q1 FY2026, down 71.8% from a year earlier and up 1.6% from the prior quarter.
Context
- Total assets increased in 1 of the last 2 fiscal years.
- FY2025 was the lowest annual figure in the 3 fiscal years shown.
What to watch
Whether total assets keeps falling in the next quarterly balance sheet after a -71.8% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Assets history
USD · from the balance sheet
- Latest · FY2025
- 12.1M USD
- Year-over-year change
- -83.6%
- 2-year CAGR
- -58.6%
| Period | Period end | Total Assets | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 12.1M | -83.6% |
| FY2024 | 2024-12-31 | 73.81M | +4.7% |
| FY2023 | 2023-12-31 | 70.47M | — |
Total Assets vs competitors
How AFJK compares with its peers on the latest reported figures
- AFJK's Mar 2026 total assets of $12.29M is the 7th highest of the 8 companies compared; the peer median is $59.31M.
- Its year-over-year change of -71.8% is the lowest of 7, against a peer median of -7.7%.
| Company | Period | Latest balance | YoY | 3-year CAGR |
|---|---|---|---|---|
| Dec 2025 | $535.74M | +10.6% | +7.1% | |
KOYNCSLM Digital Asset Acquisition Corp III Class A Ordinary Shares | Mar 2026 | $238.27M | +215959.1% | — |
ORIQUOrigin Investment Corp I Units | Mar 2026 | $72.64M | — | — |
UYSCUY Scuti Acquisition Corp. | Dec 2025 | $59.31M | +16654.8% | — |
| Mar 2026 | $37.74M | -26.0% | — | |
EURKEureka Acquisition Corp Class A Ordinary Share | Mar 2026 | $33.01M | -44.8% | — |
AFJKAimei Health Technology Co., Ltd | Mar 2026 | $12.29M | -71.8% | — |
| Mar 2026 | $12.14M | -70.0% | — | |
| Peer median (excluding AFJK) | $59.31M | -7.7% | +7.1% | |
Competitors are the stored peer set for AFJK. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|
| Cash & Equivalents | 580.72K | 28.21K | 2.93K |
| Short-term Investments | 0 | 0 | 0 |
| Net Receivables | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 |
| Other Current Assets | 0 | 0 | 0 |
| Total Current Assets | 580.72K | 30.38K | 2.93K |
| Property, Plant & Equipment (Net) | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 |
| Long-term Investments | 69.89M | 73.78M | 12.1M |
| Tax Assets | 0 | 0 | 0 |
| Other Non-current Assets | (1) | 0 | 0 |
| Total Non-current Assets | 69.89M | 73.78M | 12.1M |
| Total Assets | 70.47M | 73.81M | 12.1M |
| Account Payables | 0 | 0 | 0 |
| Short-term Debt | 0 | 227.7K | 2.02M |
| Tax Payables | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 |
| Other Current Liabilities | 0 | 0 | 0 |
| Total Current Liabilities | 24.84K | 816.99K | 3.37M |
| Long-term Debt | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 |
| Other Non-current Liabilities | 690K | 690K | 690K |
| Total Non-current Liabilities | 690K | 690K | 690K |
| Total Liabilities | 714.84K | 1.51M | 4.06M |
| Common Stock | 69.89M | 73.78M | 12.1M |
| Retained Earnings | (134.34K) | (1.48M) | (4.06M) |
| Accumulated OCI | 0 | 0 | 0 |
| Other Stockholders Equity | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 |
| Total Equity | 69.76M | 72.31M | 8.04M |
| Total Debt | 0 | 227.7K | 2.02M |
| Net Debt | (580.72K) | 199.49K | 2.02M |
Aimei Health Technology Co., Ltd
NASDAQ:AFJK
Intrinsic Alpha fair value
Locked
Current Price
$11.96
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.